Northwire Canada EditionMonday, July 13, 2026
Northwire
S 0.115 −25.8% OMI 0.310 −1.6% BMM 4.02 +5.8% CGD 0.630 +10.5% OCG 0.260 −7.1% CAMB 0.950 −5.0% HMR 0.600 −3.2% GOFL 0.025 +0.0% SIG 0.990 −3.9% SGQ 0.400 +33.3% AMCO 0.225 −10.0% TRS 0.055 +0.0% RRI 0.260 −1.9% GAL 0.400 +0.0% LIB 0.790 −13.2% SMY 0.275 +17.0% S 0.115 −25.8% OMI 0.310 −1.6% BMM 4.02 +5.8% CGD 0.630 +10.5% OCG 0.260 −7.1% CAMB 0.950 −5.0% HMR 0.600 −3.2% GOFL 0.025 +0.0% SIG 0.990 −3.9% SGQ 0.400 +33.3% AMCO 0.225 −10.0% TRS 0.055 +0.0% RRI 0.260 −1.9% GAL 0.400 +0.0% LIB 0.790 −13.2% SMY 0.275 +17.0%
Earnings

Promino Nutritional resumes trading

MUSL · Price

Executive Summary

  • Promino Nutritional Sciences Inc. has resumed trading on the Canadian Securities Exchange (CSE) after a trading halt that began on May 8, 2025, which was lifted following the filing of its 2024 audited financial statements and 2025 interim reports.
  • The company reported record sales growth for 2025, with revenues exceeding $1.88 million through October 31, representing a 523% increase over calendar year 2024 revenue of $289,000.
  • Key operational milestones include surpassing $1 million in Amazon sales for its Rejuvenate Muscle Health product, expanding retail presence to over 8,000 North American locations, and launching a new proprietary formula expected to reduce annual operating expenses by over $550,000 starting in fiscal 2026.

Key Details

  • Trading Status: Trading resumed on the CSE effective the date of the release; the previous halt was in effect since May 8, 2025.
  • 2025 Financial Performance (Year-to-Date through Oct 31):
    • Total Revenue: >$1.88 million.
    • Calendar Year 2024 Revenue: $289,000.
    • Growth Rate: 523% increase.
    • Cost of Revenues: $1.2 million.
    • Gross Profit: Positive margins achieved.
  • Amazon Sales Performance:
    • Product: Rejuvenate Muscle Health.
    • YTD Sales: >$1 million.
    • Units Sold: >23,000 units since January 2025.
    • Ranking: Top 50 in the protein drinks category on Amazon.com.
    • Margins: Positive gross margins.
  • Retail Expansion:
    • New U.S. pharmacy doors added in July 2025: >4,600.
    • Total North American store count: >8,000 locations.
  • Product & Cost Savings:
    • Launch of a new royalty-free amino acid blend.
    • Expected reduction in annual operating expenses: >$550,000 beginning in fiscal year 2026.
  • Management Changes:
    • Appointment of Moira Ong as Chief Financial Officer to improve financial discipline and internal controls.
  • Future Outlook & Financing:
    • Company is seeking further financing (equity, debentures, or loans) to finance production needs for the remainder of 2025 and through 2026.
    • E-commerce sales were moderated to manage inventory constraints.

Notable Quotes

  • "To our loyal shareholders -- thank you for your patience and belief in Promino during this extended pause. We took corrective action, including appointing Moira Ong as CFO, to ensure financial and operational discipline and to improve internal controls in Promino. Our turnaround is progressing well. Revenue is growing and both e-commerce and retail channels are demonstrating meaningful traction, and these are the first steps to position Promino for sustainable and profitable growth." — Vito Sanzone, CEO
  • "The foundation we have built over the past year, the recent traction with both Amazon and direct to consumer, and ongoing shareholder support gives us confidence that we will see continued strong growth through 2026." — Vito Sanzone, CEO
Read the original news release →

More from Promino Nutritional Sciences Inc